Selected article for: "acute respiratory syndrome coronavirus and loss taste"
Author: Shehata, Ghaydaa A.; Lord, Kevin C.; Grudzinski, Michaela C.; Elsayed, Mohamed; Abdelnaby, Ramy; Elshabrawy, Hatem A.
Title: Neurological Complications of COVID-19: Underlying Mechanisms and Management
  • Cord-id: old8wyr6
  • Document date: 2021_4_15
    • ID: old8wyr6
    Snippet: COVID-19 is a severe respiratory disease caused by the newly identified human coronavirus (HCoV) Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The virus was discovered in December 2019, and in March 2020, the disease was declared a global pandemic by the World Health Organization (WHO) due to a high number of cases. Although SARS-CoV-2 primarily affects the respiratory system, several studies have reported neurological complications in COVID-19 patients. Headache, dizziness, loss
    Document: COVID-19 is a severe respiratory disease caused by the newly identified human coronavirus (HCoV) Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The virus was discovered in December 2019, and in March 2020, the disease was declared a global pandemic by the World Health Organization (WHO) due to a high number of cases. Although SARS-CoV-2 primarily affects the respiratory system, several studies have reported neurological complications in COVID-19 patients. Headache, dizziness, loss of taste and smell, encephalitis, encephalopathy, and cerebrovascular diseases are the most common neurological complications that are associated with COVID-19. In addition, seizures, neuromuscular junctions’ disorders, and Guillain–Barré syndrome were reported as complications of COVID-19, as well as neurodegenerative and demyelinating disorders. However, the management of these conditions remains a challenge. In this review, we discuss the prevalence, pathogenesis, and mechanisms of these neurological sequelae that are secondary to SARS-CoV-2 infection. We aim to update neurologists and healthcare workers on the possible neurological complications associated with COVID-19 and the management of these disease conditions.

    Search related documents:
    Co phrase search for related documents
    • abnormal appearance and acute respiratory: 1, 2, 3, 4, 5
    • abnormal appearance and acute respiratory syndrome: 1, 2, 3, 4, 5
    • abnormal finding and acute ards respiratory distress syndrome: 1
    • abnormal finding and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abnormal finding and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7
    • absence presence and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • absence presence and acute ischemic stroke: 1, 2, 3, 4, 5, 6, 7
    • absence presence and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absence presence and ad develop: 1
    • activate immune cell and acute respiratory: 1
    • activate immune cell and acute respiratory syndrome: 1
    • active ischemic and acute ischemic stroke: 1